drugset / Trial / NCT06782659

Study to Compare the Effects of Viagra® Vs Hezkue® in Healthy Fasted Male Participants.

NCT06782659

Phase 1 Not yet recruiting 56 enrolled Aspargo Labs, Inc
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of this phase 1, open-label, single-center, two-way crossover trial is to evaluate the pharmacokinetics (PK), safety, and tolerability of 100 mg ASP-001 oral liquid suspension versus 100 mg Viagra (sildenafil citrate) tablets in fasted, healthy male volunteers

Timeline

Start
2025-01
Primary completion
2025-03
Completion
2025-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 100 mg Oral

Indications